These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 26734887)

  • 21. Brucellosis and type IV secretion.
    de Jong MF; Tsolis RM
    Future Microbiol; 2012 Jan; 7(1):47-58. PubMed ID: 22191446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brucella evasion of adaptive immunity.
    Martirosyan A; Gorvel JP
    Future Microbiol; 2013 Feb; 8(2):147-54. PubMed ID: 23374122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [MOLECULAR ASPECTS OF BRUCELLA PERSISTENCE].
    Kulakov Yu K
    Mol Gen Mikrobiol Virusol; 2016; 34(1):3-8. PubMed ID: 27183714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions.
    de Figueiredo P; Ficht TA; Rice-Ficht A; Rossetti CA; Adams LG
    Am J Pathol; 2015 Jun; 185(6):1505-17. PubMed ID: 25892682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis and immune response in Brucella infection acquired by the respiratory route.
    Ferrero MC; Alonso Paiva IM; Muñoz González F; Baldi PC
    Microbes Infect; 2020 Oct; 22(9):407-415. PubMed ID: 32535086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Mechanism of Facultative Intracellular Parasitism of
    Jiao H; Zhou Z; Li B; Xiao Y; Li M; Zeng H; Guo X; Gu G
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymptomatic brucellosis infection in humans: implications for diagnosis and prevention.
    Zhen Q; Lu Y; Yuan X; Qiu Y; Xu J; Li W; Ke Y; Yu Y; Huang L; Wang Y; Chen Z
    Clin Microbiol Infect; 2013 Sep; 19(9):E395-7. PubMed ID: 23668532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type IV secretion system of Brucella spp. and its effectors.
    Ke Y; Wang Y; Li W; Chen Z
    Front Cell Infect Microbiol; 2015; 5():72. PubMed ID: 26528442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of SP41, a surface protein of Brucella associated with adherence and invasion of host epithelial cells.
    Castañeda-Roldán EI; Ouahrani-Bettache S; Saldaña Z; Avelino F; Rendón MA; Dornand J; Girón JA
    Cell Microbiol; 2006 Dec; 8(12):1877-87. PubMed ID: 16817909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brucella adaptation and survival at the crossroad of metabolism and virulence.
    Barbier T; Nicolas C; Letesson JJ
    FEBS Lett; 2011 Oct; 585(19):2929-34. PubMed ID: 21864534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions.
    Salcedo SP; Marchesini MI; Degos C; Terwagne M; Von Bargen K; Lepidi H; Herrmann CK; Santos Lacerda TL; Imbert PR; Pierre P; Alexopoulou L; Letesson JJ; Comerci DJ; Gorvel JP
    Front Cell Infect Microbiol; 2013; 3():28. PubMed ID: 23847770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards a Brucella vaccine for humans.
    Perkins SD; Smither SJ; Atkins HS
    FEMS Microbiol Rev; 2010 May; 34(3):379-94. PubMed ID: 20180858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brucella - Virulence Factors, Pathogenesis and Treatment.
    Głowacka P; Żakowska D; Naylor K; Niemcewicz M; Bielawska-Drózd A
    Pol J Microbiol; 2018 Jun; 67(2):151-161. PubMed ID: 30015453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Persistence of brucellosis L cultures in the body of an experimental animal and the duration of immunity].
    Vershilova PA; Grekova NA; Tolmacheva TA
    Vestn Akad Med Nauk SSSR; 1985; (3):10-3. PubMed ID: 3922151
    [No Abstract]   [Full Text] [Related]  

  • 35. Bartonella and Brucella--weapons and strategies for stealth attack.
    Ben-Tekaya H; Gorvel JP; Dehio C
    Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23906880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis.
    Gomez G; Adams LG; Rice-Ficht A; Ficht TA
    Front Cell Infect Microbiol; 2013; 3():17. PubMed ID: 23720712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiology of Brucella.
    Percin D
    Recent Pat Antiinfect Drug Discov; 2013 Apr; 8(1):13-7. PubMed ID: 22812617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophages and Brucella.
    Baldwin CL; Winter AJ
    Immunol Ser; 1994; 60():363-80. PubMed ID: 8251581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory techniques in brucellosis.
    Alton GG; Jones LM; Pietz DE
    Monogr Ser World Health Organ; 1975; (55):1-163. PubMed ID: 812265
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence of Brucella antibodies after acute brucellosis.
    Almuneef M; Memish ZA
    J Chemother; 2003 Apr; 15(2):148-51. PubMed ID: 12797392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.